Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial

Fertility and Sterility

Volumn 96, Issue 5, 2011, Pages 1128-1133

  Palomba, Stefano ^a   Falbo, Angela ^a   Di Cello, Annalisa ^a   Cappiello, Fulvio ^b   Tolino, Achille ^c   Zullo, Fulvio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b IVF Center   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Gonadotropins; infertility; IVF; metformin; PCOS; poor prognosis; poor responder

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LEUPRORELIN; METFORMIN; PLACEBO; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; METAPHASE; MULTICENTER STUDY; OOCYTE; OVARIAN RESERVE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; EARLY TERMINATION OF CLINICAL TRIALS; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; ITALY; METFORMIN; OVARY; OVULATION; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 80054996030     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.08.020     Document Type: Article

References (37)

1. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome Hum Reprod 23 2008 462 477
2. M.F. Costello, M. Chapman, and U. Conway A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome Hum Reprod 21 2006 1387 1399
3. L.O. Tso, M.F. Costello, L.E. Albuquerque, R.B. Andriolo, and V. Freitas Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome Cochrane Database Syst Rev 2 2009 CD006105
4. S. Palomba, A. Falbo, F. Zullo, and F. Orio Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review Endocr Rev 30 2009 1 50
5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
6. B.A. Malizia, M.R. Hacker, and A.S. Penzias Cumulative live-birth rates after in vitro fertilization N Engl J Med 360 2009 236 243
7. I. Kligman, and Z. Rosenwaks Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders Fertil Steril 76 2001 1185 1190
8. L.L. van Loendersloot, M. van Wely, J. Limpens, P.M. Bossuyt, S. Repping, and F. van der Veen Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis Hum Reprod Update 16 2010 577 589
9. D. Moher, K.F. Schultz, and D.G. Altman The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomised trials Lancet 357 2001 1191 1194
10. L.A. Scott, R. Alvero, M. Leondires, and B.T. Miller The morphology of human pronuclear embryos is positively related to blastocyst development and implantation Hum Reprod 15 2000 2394 2403
11. L.L. Veeck An atlas of human gametes and conceptuses: an illustrated reference for assisted reproductive technology 1999 CRC Press-Parthenon New York
12. F. Zegers-Hochschild, G.D. Adamson, J. de Mouzon, O. Ishihara, R. Mansour, and K. Nygren International Committee for Monitoring Assisted Reproductive Technology; World Health Organization. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009 Hum Reprod 24 2009 2683 2687
13. S. Palomba, T. Russo, F. Orio Jr., A. Falbo, A. Tolino, and F. Zullo Perifollicular vascularity assessment for selecting the best oocytes for in vitro fertilization programs in older patients Fertil Steril 90 2008 1305 1309
14. K.K.G. Lan, and D.L. DeMets Discrete sequential boundaries for clinical trials Biometrika 70 1983 659 663
15. E.M. Heijnen, M.J. Eijkemans, E.G. Hughes, J.S. Laven, N.S. Macklon, and B.C. Fauser A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome Hum Reprod Update 12 2006 13 21
16. B.C. Tarlatzis, L. Zepiridis, G. Grimbizis, and J. Bontis Clinical management of low ovarian response to stimulation for IVF: a systematic review Hum Reprod Update 9 2003 61 76
17. I. Kligman, and Z. Rosenwaks Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders Fertil Steril 76 2001 1185 1190
18. Z. Wei, Y. Cao, L. Cong, P. Zhou, Z. Zhang, and J. Li Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome Fertil Steril 90 2008 1149 1154
19. S. Palomba, A. Falbo, F. Orio, and F. Zullo Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials Fertil Steril 92 2009 1646 1658
20. J.E. Nestler, and D.J. Jakubowicz Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 335 1996 617 623
21. J.E. Nestler, and D.J. Jakubowicz Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens J Clin Endocrinol Metab 82 1997 4075 4079
22. G.R. Attia, W.E. Rainey, and B.R. Carr Metformin directly inhibits androgen production in human thecal cells Fertil Steril 76 2001 517 524
23. G.F. Erickson, D.A. Magoffin, J.R. Cragun, and R.J. Chang The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries J Clin Endocrinol Metab 70 1990 894 902
24. B. Sonnatag, M. Gotte, P. Wiilfing, A.N. Schuring, L. Kiesel, and R.R. Greb Metformin alters insulin signaling and viability of human granulosa cells Fertil Steril 84 2005 1173 1179
25. L. Tosca, P. Solnais, P. Ferr, F. Foufelle, and J. Dupont Metformin-induced stimulation of adenosine 5′ monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells Biol Reprod 75 2006 342 351
26. L. Tosca, C. Chabrolle, S. Uzbekova, and J. Dupont Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5′ monophosphate-activated protein kinase (AMPK) Biol Reprod 76 2007 368 378
27. S. Coyral-Castel, L. Tosca, G. Ferreira, E. Jeanpierre, C. Rame, and D. Lomet The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats J Neuroendocrinol 20 2008 335 346
28. S. Palomba, A. Falbo, T. Russo, F. Orio, A. Tolino, and F. Zullo Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response Hum Reprod 25 2010 1005 1013
29. L.A. Stadtmauer, S.K. Toma, R.M. Riehl, and L.M. Talbert Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors Fertil Steril 75 2001 505 509
30. M.E. Nielsen, I.A. Rasmussen, S.G. Kristensen, S.T. Christensen, K. Møllgrd, and E. Wreford Andersen In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA Mol Hum Reprod 17 2011 63 70
31. S. Weil, K. Vendola, J. Zhou, and C.A. Bondy Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development J Clin Endocrinol Metab 84 1999 2951 2956
32. N. Massin, I. Cedrin-Durnerin, C. Coussieu, J. Galey-Fontaine, J.P. Wolf, and J.N. Hugues Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique - a prospective, randomized, double-blind study Hum Reprod 21 2006 1204 1211
33. K. Lossl, C.Y. Andersen, A. Loft, N.L. Freiesleben, S. Bangsbøll, and A.N. Andersen Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial Hum Reprod 23 2008 1820 1829
34. G. Anifandis, E. Koutselini, I. Stefanidis, V. Liakopoulos, C. Leivaditis, and T. Mantzavinos Serum and follicular fluid leptin levels are correlated with human embryo quality Reproduction 130 2005 917 921
35. S.M. Carlsen, E. Vanky, and R. Fleming Anti-müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome Hum Reprod 24 2009 1732 1738
36. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A.C. Artenisio Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update 16 2010 113 130
37. L.G. de Aguiar, L.R. Bahia, N. Villela, C. Laflor, F. Sicuro, and N. Wiernsperger Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance Diabetes Care 29 2006 1083 1089